Harvard Bioscience Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
25,771.00
14,134.00
6,744.00
5,596.00
5,733.00
8,173
Total Accounts Receivable
17,655.00
16,141.00
17,547.00
15,746.00
16,236.00
21,463
Inventories
15,777.00
20,531.00
22,343.00
19,955.00
21,353.00
25,087
Other Current Assets
1,547.00
4,742.00
3,915.00
4,175.00
4,213.00
3,109
Total Current Assets
60,750.00
55,548.00
50,549.00
45,472.00
47,535.00
57,832
Net Property, Plant & Equipment
4,375.00
5,190.00
5,902.00
4,296.00
4,140.00
5,898
Intangible Assets
56,903.00
62,227.00
62,452.00
56,712.00
57,173.00
103,068
Other Assets
316.00
1,895.00
152.00
128.00
324.00
1,604
Total Assets
135,460.00
135,916.00
120,050.00
107,765.00
109,354.00
168,613
ST Debt & Current Portion LT Debt
5,000.00
5,000.00
2,364.00
2,372.00
2,765.00
Accounts Payable
4,682.00
6,294.00
8,782.00
6,196.00
5,404.00
Income Tax Payable
99.00
675.00
2,536.00
223.00
387.00
Other Current Liabilities
6,304.00
6,130.00
5,641.00
5,810.00
5,485.00
Total Current Liabilities
16,085.00
18,099.00
19,323.00
14,601.00
14,041.00
Long-Term Debt
19,750.00
16,450.00
16,369.00
11,374.00
8,983.00
Provision for Risks & Charges
4,900.00
4,446.00
2,800.00
3,000.00
1,200.00
Deferred Taxes
12,956.00
9,731.00
2,780.00
5,260.00
3,782.00
Other Liabilities
80.00
128.00
185.00
177.00
266.00
Total Liabilities
40,975.00
40,448.00
42,452.00
35,569.00
28,454.00
Common Equity (Total)
94,485.00
95,468.00
77,598.00
72,196.00
80,900.00
Total Shareholders' Equity
94,485.00
95,468.00
77,598.00
72,196.00
80,900.00
Total Equity
94,485.00
95,468.00
77,598.00
72,196.00
80,900.00
Liabilities & Shareholders' Equity
135,460.00
135,916.00
120,050.00
107,765.00
109,354.00
About Harvard Bioscience
View Profile
